3-(4-Chlorophenyl)oxetane-3-carboxylic acid, 97%, 1g

(R)-2-Amino-2-(4-aminophenyl)acetic acid dihydrochloride, 97.0%, 250mg

Carbonato di sodio, minimo 99,5%, Ph.Eur., USP, BP, anidro, 5 kg, confezione in plastica.

8-(4-bromophenyl)-8-oxooctanenitrile, 97.0%, 1g

tert-Butyl ((3R,4R)-4-hydroxypyrrolidin-3-yl)carbamate, 97.0%, 1g

2,5-Difluoro-7,7,8,8-tetracyanoquinodimethane>98.0%(N)100mg

(2E)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)acrylic acid, 1g

1-Methyl-1,4-diazepan-2-one hydrochloride, 95.0%, 1g

2,5-Bis(2,2'-bipyridin-6-yl)-1,1-dimethyl-3,4-diphenylsilole>98.0%(HPLC)(N)200mg

3-(tert-Butyl)-1,2,4-oxadiazole-5-carboxylic acid, 98%, 100mg

3-Amino-5-benzylthio-1,2,4-thiadiazole, 97.0%, 100mg

2,3-Diphenylindole, 95.0%, 10g

Obiettivo IOS piano PLMi S100x/0,85 corretto all'infinito. Distanza di lavoro 0,4 mm